What Is GHK-Cu?
GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide found in human plasma, saliva, and urine. It was first isolated by Loren Pickart in the 1970s and has been studied for over 50 years — making it one of the longest-researched peptides in the cosmetic and regenerative biology space. GHK-Cu is a copper-binding peptide: the copper ion (Cu²⁺) is a core part of its biological activity, not just a tag-along. It is available in topical formulations without a prescription and is also sold as a research chemical for injectable use.
Skin: Where the Evidence Is Strongest
The cosmetic evidence base for GHK-Cu is more robust than for any other peptide commonly found in skincare. Multiple in vitro and clinical studies show it stimulates collagen and elastin production, promotes angiogenesis in skin tissue, accelerates wound healing, and demonstrates antioxidant activity. A study in the International Journal of Cosmetic Science documented statistically significant improvements in skin laxity, density, and fine line depth in women using GHK-Cu formulations. Its safety record from decades of cosmetic use is also well-established.
Beyond Skin: Systemic and Longevity Research
Loren Pickart's later research, along with subsequent gene expression studies, suggests GHK-Cu's effects extend well beyond skin. A 2012 analysis published in Biochemistry found that GHK-Cu modulates over 4,000 human genes — including genes associated with inflammation, tissue remodeling, pain signaling, and stem cell pathways. Research in rodent models has shown it reduces anxiety behaviors, promotes nerve regeneration, and exhibits anti-cancer properties in cell culture. These findings are early-stage and not yet supported by human clinical trials for systemic use.
Enjoying this? Get weekly peptide research in your inbox →
Topical vs Injectable: What the Evidence Covers
The clinical evidence for GHK-Cu is almost entirely based on topical application. Penetration into deeper skin layers is a real challenge — most peptides are too large to cross the stratum corneum efficiently without carrier technology. Formulation matters enormously: a GHK-Cu cream with poor penetration enhancers will not deliver the same effect as one optimized for skin delivery. Injectable GHK-Cu is sold as a research chemical and used by researchers interested in systemic effects, but this application has no published human trial data.
How GHK-Cu Compares to Other Cosmetic Peptides
Most cosmetic peptides have weak or manufacturer-funded evidence. GHK-Cu stands apart because its research base is independent, extensive, and spans multiple decades and labs. Argireline (Acetyl hexapeptide-3) has modest clinical evidence for wrinkle reduction. Palmitoyl pentapeptide-4 (Matrixyl) has some collagen-stimulation data. Neither approaches GHK-Cu's depth of published literature. If you're evaluating a skincare formulation's peptide credentials, GHK-Cu concentration and formulation quality is the most evidence-backed item to scrutinize.